Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients

Limited data exists on SARS-CoV-2 sustained-response to vaccine in patients with rheumatic diseases. This study aims to evaluate neutralizing antibodies (nAB) induced by SARS-CoV-2 vaccine after 3 to 6 months from administration in Systemic Lupus Erythematosus (SLE) patients, as a surrogate of susta...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Cirera, Silvia, Calvet, Joan, Berenguer-Llergo, Antoni, Pradenas, Edwards, Marfil, Silvia, Massanella, Marta, Mateu, Lourdes, Trinité, Benjamin, Llop, Maria, Arévalo, Marta, Galisteo, Carlos, Orellana, Cristóbal, Gómez, Rafael, Gómez-Gerique, María Nieves, Carmona, Inma, Clotet, Bonaventura, Blanco, Julià, Gratacós, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427088/
https://www.ncbi.nlm.nih.gov/pubmed/36042275
http://dx.doi.org/10.1038/s41598-022-18996-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427088/
https://www.ncbi.nlm.nih.gov/pubmed/36042275
http://dx.doi.org/10.1038/s41598-022-18996-x

Ejemplares similares